SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-21-000336
Filing Date
2021-01-20
Accepted
2021-01-20 11:14:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 MOLECULIN BIOTECH, INC. p21-0140sc13ga.htm SC 13G/A 75487
  Complete submission text file 0000902664-21-000336.txt   76985
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Subject) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89866 | Film No.: 21537764
SIC: 2834 Pharmaceutical Preparations